Same molecule but different expression: Aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin

Journal of Pineal Research

Volumn 60, Issue 2, 2016, Pages 193-205

  Volt, Huayqui ^a,b   García, José A ^a,b   Doerrier, Carolina ^a,b   Díaz Casado, María E ^a,b   Guerra Librero, Ana ^a,b   Lõpez, Luis C ^a,b   Escames, Germaine ^a,b   Tresguerres, Jesús A ^c   Acuña Castroviejo, Darío ^a,b,d  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

clock genes; inflammaging; melatonin; mitochondria; NF B; NLRP3 inflammasome

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; MELATONIN; TRANSCRIPTION FACTOR CLOCK; CARRIER PROTEIN; NLRP3 PROTEIN, MOUSE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENERGY; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; INFLAMMATION; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SEPSIS; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY;

AGING; ANIMALS; CARRIER PROTEINS; GENE EXPRESSION REGULATION; INFLAMMASOMES; MALE; MELATONIN; MICE; NF-KAPPA B; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; SEPSIS;

EID: 84956884053     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12303     Document Type: Article

References (83)

1. Zang QS, Wolf SE, Minei JP,. Sepsis-induced cardiac mitochondrial damage and potential therapeutic interventions in the elderly. Aging Dis 2014; 5: 137-149.
2. Starr ME, Saito H,. Sepsis in old age: review of human and animal studies. Aging Dis 2014; 5: 126-136.
3. de Gaudio AR, Rinaldi S, Chelazzi C, et al., Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations. Curr Drug Targets 2009; 10: 60-70.
4. Hunter JD, Doddi M,. Sepsis and the heart. Br J Anaesth 2010; 104: 3-11.
5. Vincent JL, Marshall JC, Namendys-Silva SA, et al., Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med 2014; 2: 380-386.
6. Saito H, Sherwood ER, Varma TK, et al., Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech Ageing Dev 2003; 124: 1047-1058.
7. Opal SM, Girard TD, Ely EW,. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 2005; 41 (Suppl 7): S504-S512.
8. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al., Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev 2013; 93: 1247-1288.
9. Franceschi C, Bonafe M, Valensin S, et al., Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-254.
10. Baylis D, Bartlett DB, Patel HP, et al., Understanding how we age: insights into inflammaging. Longev Healthspan 2013; 2: 8.
11. Hyde SR, Stith RD, McCallum RE,. Mortality and bacteriology of sepsis following cecal ligation and puncture in aged mice. Infect Immun 1990; 58: 619-624.
12. Cohen J,. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
13. Pahl HL,. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-6866.
14. Salminen A, Huuskonen J, Ojala J, et al., Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 2008; 7: 83-105.
15. Zhang G, Li J, Purkayastha S, et al., Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH. Nature 2013; 497: 211-216.
16. Liu SF, Malik AB,. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 2006; 290: L622-L645.
17. Bauernfeind FG, Horvath G, Stutz A, et al., Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183: 787-791.
18. Schroder K, Zhou R, Tschopp J,. The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010; 327: 296-300.
19. Tschopp J,. Mitochondria: Sovereign of inflammation? Eur J Immunol 2011; 41: 1196-1202.
20. Zhou R, Yazdi AS, Menu P, et al., A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-225.
21. Salminen A, Kaarniranta K, Kauppinen A,. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 2012; 4: 166-175.
22. Green DR, Galluzzi L, Kroemer G,. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011; 333: 1109-1112.
23. Akashi M, Takumi T,. The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 2005; 12: 441-448.
24. Crumbley C, Wang Y, Kojetin DJ, et al., Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha/RORalpha target gene. J Biol Chem 2010; 285: 35386-35392.
25. +-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008; 134: 329-340.
26. Yeung F, Hoberg JE, Ramsey CS, et al., Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380.
27. Escames G, Lopez LC, Garcia JA, et al., Mitochondrial DNA and inflammatory diseases. Hum Genet 2012; 131: 161-173.
28. Galley HF,. Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Crit Care 2010; 14: 230.
29. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
30. Manchester LC, Coto-Montes A, Boga JA, et al., Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 2015; 59: 403-419.
31. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
32. Lopez A, Garcia JA, Escames G, et al., Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 2009; 46: 188-198.
33. Acuna CD, Lopez LC, Escames G, et al., Melatonin-mitochondria interplay in health and disease. Curr Top Med Chem 2011; 11: 221-240.
34. Martin M, Macias M, Escames G, et al., Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J 2000; 14: 1677-1679.
35. Crespo E, Macias M, Pozo D, et al., Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999; 13: 1537-1546.
36. Escames G, Lopez LC, Tapias V, et al., Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J Pineal Res 2006; 40: 71-78.
37. Tan DX, Manchester LC, Burkhardt S, et al., N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15: 2294-2296.
38. García JA, Volt H, Venegas C, et al., Disruption of the NF-kappaB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-alpha and blocks the septic response in mice. FASEB J 2015; 29: 3863-3875.
39. Ortiz F, Acuña-Castroviejo D, Doerrier C, et al., Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis. J Pineal Res 2015; 58: 34-49.
40. Rittirsch D, Huber-Lang MS, Flierl MA, et al., Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4: 31-36.
41. Jaskot RH, Charlet EG, Grose EC, et al., An automated analysis of glutathione peroxidase, S-transferase, and reductase activity in animal tissue. J Anal Toxicol 1983; 7: 86-88.
42. Misra HP, Fridovich I,. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-3175.
43. Aebi H,. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
44. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
45. Pesta D, Gnaiger E,. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 2012; 810: 25-58.
46. Birch-Machin MA, Briggs HL, Saborido AA, et al., An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol 1994; 51: 35-42.
47. Kobzik L, Stringer B, Balligand JL, et al., Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun 1995; 211: 375-381.
48. Kirby DM, Thorburn DR, Turnbull DM, et al., Biochemical assays of respiratory chain complex activity. Methods Cell Biol 2007; 80: 93-119.
49. Kale SS, Yende S,. Effects of aging on inflammation and hemostasis through the continuum of critical illness. Aging Dis 2011; 2: 501-511.
50. Acuña-Castroviejo D, Carretero M, Doerrier C, et al., Melatonin protects lung mitochondria from aging. Age (Dordr) 2012; 34: 681-692.
51. Carretero M, Escames G, Lopez LC, et al., Long-term melatonin administration protects brain mitochondria from aging. J Pineal Res 2009; 47: 192-200.
52. Rodríguez MI, Carretero M, Escames G, et al., Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice. Free Radic Res 2007; 41: 15-24.
53. Rodríguez MI, Escames G, Lopez LC, et al., Melatonin administration prevents cardiac and diaphragmatic mitochondrial oxidative damage in senescence-accelerated mice. J Endocrinol 2007; 194: 637-643.
54. Escames G, Lopez LC, Ortiz F, et al., Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice. FEBS J 2007; 274: 2135-2147.
55. Ortiz F, Garcia JA, Acuna-Castroviejo D, et al., The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS. J Pineal Res 2014; 56: 71-81.
56. Ueda HR, Hayashi S, Chen W, et al., System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet 2005; 37: 187-192.
57. Kong S, McBurney MW, Fang D,. Sirtuin 1 in immune regulation and autoimmunity. Immunol Cell Biol 2012; 90: 6-13.
58. Dubrovsky YV, Samsa WE, Kondratov RV,. Deficiency of circadian protein CLOCK reduces lifespan and increases age-related cataract development in mice. Aging (Albany NY) 2010; 2: 936-944.
59. Kondratov RV, Kondratova AA, Gorbacheva VY, et al., Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev 2006; 20: 1868-1873.
60. Preitner N, Damiola F, Lopez-Molina L, et al., The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002; 110: 251-260.
61. Sato TK, Panda S, Miraglia LJ, et al., A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 2004; 43: 527-537.
62. Donmez G, Guarente L,. Aging and disease: connections to sirtuins. Aging Cell 2010; 9: 285-290.
63. De MM, Franceschi C, Monti D, et al., Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006; 80: 219-227.
64. Latz E,. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010; 22: 28-33.
65. Cannizzo ES, Clement CC, Sahu R, et al., Oxidative stress, inflamm-aging and immunosenescence. J Proteomics 2011; 74: 2313-2323.
66. Basha PM, Poojary A,. Mitochondrial dysfunction in aging rat brain regions upon chlorpyrifos toxicity and cold stress: an interactive study. Cell Mol Neurobiol 2014; 34: 737-756.
67. Chan DC,. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006; 125: 1241-1252.
68. Green DR, Kroemer G,. Cytoplasmic functions of the tumour suppressor p53. Nature 2009; 458: 1127-1130.
69. Han MK, Song EK, Guo Y, et al., SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2008; 2: 241-251.
70. Gomes AP, Price NL, Ling AJ, et al., Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 2013; 155: 1624-1638.
71. Yoshino J, Mills KF, Yoon MJ, et al., Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 2011; 14: 528-536.
72. Kim BC, Kim HT, Mamura M, et al., Tumor necrosis factor induces apoptosis in hepatoma cells by increasing Ca(2 +) release from the endoplasmic reticulum and suppressing Bcl-2 expression. J Biol Chem 2002; 277: 31381-31389.
73. Acuña-Castroviejo D, Reiter RJ, Menendez-Pelaez A, et al., Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver. J Pineal Res 1994; 16: 100-112.
74. Carlberg C, Wiesenberg I,. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship. J Pineal Res 1995; 18: 171-178.
75. Wiesenberg I, Missbach M, Kahlen JP, et al., Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res 1995; 23: 327-333.
76. Wiesenberg I, Missbach M, Carlberg C,. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 1998; 12: 143-150.
77. Vriend J, Reiter RJ,. Melatonin feedback on clock genes: a theory involving the proteasome. J Pineal Res 2015; 58: 1-11.
78. Tan DX, Manchester LC, Sainz RM, et al., Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J Pineal Res 2005; 39: 185-194.
79. Tajes M, Gutierrez-Cuesta J, Ortuno-Sahagun D, et al., Anti-aging properties of melatonin in an in vitro murine senescence model: involvement of the sirtuin 1 pathway. J Pineal Res 2009; 47: 228-237.
80. Rodríguez MI, Escames G, Lopez LC, et al., Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res 2007; 42: 272-279.
81. Reiter RJ,. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79: C153-C158.
82. Waldhauser F, Steger H,. Changes in melatonin secretion with age and pubescence. J Neural Transm Suppl 1986; 21: 183-197.
83. Waldhauser F, Weiszenbacher G, Tatzer E, et al., Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 1988; 66: 648-652.